Scientific and Regulatory Aspects of Macromolecular Drugs and Devices
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 13 (4-5) , 873-968
- https://doi.org/10.3109/03639048709105218
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tax and the business of biotechnologyTrends in Biotechnology, 1986
- In vitro immunization for production of murine and human monoclonal antibodies: Present statusTrends in Biotechnology, 1986
- Fermentation EconomicsNature Biotechnology, 1986
- Design of large scale containment facilities for recombinant DNA fermentationsTrends in Biotechnology, 1986
- New VaccinesInternational Journal of Epidemiology, 1985
- Detection of host-derived contaminants in products of recombinant DNA technology in E. coli: a comparison of silver-staining and immunoblottingJournal of Pharmacy and Pharmacology, 1985
- Monoclonal antibodies — Approaching adolescence in diagnostic immunoassaysTrends in Biotechnology, 1985
- Bulk production of monoclonal antibodies in fermentersTrends in Biotechnology, 1985
- Biotechnology: Present and Future Roles in the Pharmaceutical IndustryDrug Development and Industrial Pharmacy, 1985
- Elimination of Mycoplasma, Bacteria, and Fungi Contaminants of Hybridoma Cultures by Intraperitoneal Passage in the MouseHybridoma, 1984